We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tensions Remain Over tPA for Stroke.
- Authors
Mitka, Mike
- Abstract
Focuses on the use of tissue-type plasminogen activator (tPA) in the treatment of ischemic stroke. Controversy over using this thrombolytic agent, including the issue of administering tPA within three hours of onset; Effort of the American Stroke Association to increase the number of patients going to the emergency room within the 3-hour period; Reference to research indicating that benefits of tPA therapy outweighs the risks; Concern of emergency physicians about malpractice lawsuits; Mention of the Abciximab in Emergent Stroke Treatment Trial.
- Subjects
PLASMINOGEN activators; BRAIN disease treatment; CEREBROVASCULAR disease; THERAPEUTICS; HOSPITAL emergency services; MEDICAL malpractice; PHARMACEUTICAL research
- Publication
JAMA: Journal of the American Medical Association, 2003, Vol 289, Issue 11, p1363
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.289.11.1363